Evidence map›Paper›PMID 26598009›Full record

ArticleScientific reports2015

Identification of novel autophagic Radix Polygalae fraction by cell membrane chromatography and UHPLC-(Q)TOF-MS for degradation of neurodegenerative disease proteins.

An-Guo Wu, Vincent Kam-Wai Wong, Wu Zeng, Liang Liu, Betty Yuen-Kwan Law

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Saponin components inFrontiers in pharmacology · 2024
    Review
  5. Review
  6. Chemical Constituents of the Roots ofPlants (Basel, Switzerland) · 2022
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

An-Guo WuState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.
Vincent Kam-Wai WongState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.
Wu ZengState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.
Liang LiuState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.
Betty Yuen-Kwan LawState Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China.
Macau University of Science and Technology · MO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With its traditional use in relieving insomnia and anxiety, our previous study has identified onjisaponin B from Radix Polygalae (RP), as a novel autophagic enhancer with potential neuroprotective effects. In current study, we have further identified a novel active fraction from RP, contains 17 major triterpenoid saponins including the onjisaponin B, by the combinational use of cell membrane chromatography (CMC) and ultra-performance liquid chromatography coupled to (quadrupole) time-of-flight mass spectrometry {UHPLC-(Q)TOF-MS}. By exhibiting more potent autophagic effect in cells, the active fraction enhances the clearance of mutant huntingtin, and reduces protein level and aggregation of α-synuclein in a higher extent when compared with onjisaponin B. Here, we have reported for the first time the new application of cell-based CMC and UHPLC-(Q)TOF-MS analysis in identifying new autophagy inducers with neuroprotective effects from Chinese medicinal herb. This result has provided novel insights into the possible pharmacological actions of the active components present in the newly identified active fraction of RP, which may help to improve the efficacy of the traditional way of prescribing RP, and also provide new standard for the quality control of decoction of RP or its medicinal products in the future.

Indexed as

alpha-SynucleinAnimalsAutophagyCell MembraneChromatography, High Pressure LiquidDrugs, Chinese HerbalHuntingtin ProteinInhibitory Concentration 50Mice, KnockoutNerve Tissue ProteinsNeurodegenerative DiseasesNuclear ProteinsPC12 CellsPolygalaProteolysisRatsalpha-SynucleinDrugs, Chinese HerbalHtt protein, ratHuntingtin ProteinNerve Tissue ProteinsNuclear Proteinsonjisaponin BSaponinsTriterpenes

Identifiers

PMID26598009
PMCPMC4657008
OpenAlexW2406301238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.